Annual Operating Margin
-400.36%
-129.92%-48.04%
December 1, 2023
Summary
- As of February 6, 2025, CSCI annual operating profit margin is -400.36%, with the most recent change of -129.92% (-48.04%) on December 1, 2023.
- During the last 3 years, CSCI annual operating margin has fallen by -234.31% (-141.11%).
- CSCI annual operating margin is now -1193.58% below its all-time high of 36.61%, reached on December 1, 2018.
Performance
CSCI Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Margin
-258.36%
-97.68%-60.79%
September 1, 2024
Summary
- As of February 6, 2025, CSCI quarterly operating profit margin is -258.36%, with the most recent change of -97.68% (-60.79%) on September 1, 2024.
- Over the past year, CSCI quarterly operating margin has dropped by -99.11% (-62.24%).
- CSCI quarterly operating margin is now -101.21% below its all-time high of 21.42 thousand%, reached on December 1, 1998.
Performance
CSCI Quarterly Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Margin Formula
Operating Profit Margin = Operating Profit
Revenue ✕ 100%
Revenue ✕ 100%
CSCI Operating Margin Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -48.0% | -62.2% |
3 y3 years | -141.1% | -62.2% |
5 y5 years | -1193.6% | -62.2% |
CSCI Operating Margin Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -142.9% | at low | -716.9% | at low |
5 y | 5-year | -142.9% | +77.7% | -716.9% | at low |
alltime | all time | -1193.6% | +99.9% | -101.2% | +83.5% |
COSCIENS Biopharma Operating Margin History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | -258.36%(+60.8%) |
Jun 2024 | - | -160.68%(+82.0%) |
Mar 2024 | - | -88.27%(-44.6%) |
Dec 2023 | -400.36%(+48.0%) | -159.25%(+179.8%) |
Sep 2023 | - | -56.92%(-28.9%) |
Jun 2023 | - | -80.03%(+462.4%) |
Mar 2023 | - | -14.23%(+49.0%) |
Dec 2022 | -270.44%(+64.1%) | -9.55%(-133.9%) |
Sep 2022 | - | 28.17%(-29.7%) |
Jun 2022 | - | 40.07%(-4.3%) |
Mar 2022 | - | 41.88%(+53.3%) |
Dec 2021 | -164.85%(-0.7%) | 27.32%(+59.5%) |
Sep 2021 | - | 17.13%(-10.0%) |
Jun 2021 | - | 19.03%(+25.0%) |
Mar 2021 | - | 15.22%(-374.7%) |
Dec 2020 | -166.05%(-90.7%) | -5.54%(-150.8%) |
Sep 2020 | - | 10.90%(-61.5%) |
Jun 2020 | - | 28.28%(+26.4%) |
Mar 2020 | - | 22.38%(+167.1%) |
Dec 2019 | -1793.99%(-5000.3%) | 8.38%(-607.9%) |
Sep 2019 | - | -1.65%(-84.5%) |
Jun 2019 | - | -10.62%(+19.3%) |
Mar 2019 | - | -8.90%(-141.1%) |
Dec 2018 | 36.61%(-101.5%) | 21.64%(-3481.3%) |
Sep 2018 | - | -0.64%(-118.0%) |
Jun 2018 | - | 3.55%(-6016.7%) |
Mar 2018 | - | -0.06%(-99.9%) |
Dec 2017 | -2499.89%(-22.7%) | -54.28%(-329.7%) |
Sep 2017 | - | 23.63%(-26.9%) |
Jun 2017 | - | 32.32%(+278.9%) |
Mar 2017 | - | 8.53%(-59.5%) |
Dec 2016 | -3235.57%(-49.4%) | 21.07%(-42.2%) |
Sep 2016 | - | 36.44%(-37.1%) |
Jun 2016 | - | 57.92%(+25.8%) |
Mar 2016 | - | 46.03%(-19.7%) |
Dec 2015 | -6400.73%(-98.1%) | 57.35%(+44.8%) |
Sep 2015 | - | 39.60%(+9.8%) |
Jun 2015 | - | 36.06%(-619.6%) |
Mar 2015 | - | -6.94%(-212.5%) |
Dec 2014 | -339.95 K%(>+9900.0%) | 6.17%(-81.1%) |
Sep 2014 | - | 32.64%(+0.8%) |
Jun 2014 | - | 32.38%(+53.5%) |
Mar 2014 | - | 21.09%(-3736.2%) |
Dec 2013 | -444.96%(-69.3%) | -0.58%(-104.8%) |
Sep 2013 | - | 12.05%(-193.3%) |
Jun 2013 | - | -12.91%(-157.3%) |
Mar 2013 | - | 22.53%(-220.4%) |
Dec 2012 | -1448.42%(+114.9%) | -18.71%(+176.4%) |
Sep 2012 | - | -6.77%(-27.4%) |
Jun 2012 | - | -9.32%(-357.5%) |
Mar 2012 | - | 3.62%(-78.8%) |
Dec 2011 | -673.90%(+652.6%) | 17.07%(-562.6%) |
Sep 2011 | - | -3.69%(-128.5%) |
Jun 2011 | - | 12.94%(-50.3%) |
Mar 2011 | - | 26.05%(+87.0%) |
Dec 2010 | -89.54% | 13.93%(+59.4%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2010 | - | 8.74%(-804.8%) |
Jun 2010 | - | -1.24%(-261.0%) |
Mar 2010 | - | 0.77%(-100.9%) |
Dec 2009 | -37.89%(-76.6%) | -86.58%(-823.3%) |
Sep 2009 | - | 11.97%(-38.4%) |
Jun 2009 | - | 19.42%(+15.3%) |
Mar 2009 | - | 16.84%(-300.5%) |
Dec 2008 | -162.13%(+96.3%) | -8.40%(-82.0%) |
Sep 2008 | - | -46.58%(+112.8%) |
Jun 2008 | - | -21.89%(-57.4%) |
Mar 2008 | - | -51.34%(+49.7%) |
Dec 2007 | -82.61%(+41.8%) | -34.29%(-42.7%) |
Sep 2007 | - | -59.88%(-8084.0%) |
Jun 2007 | - | 0.75%(-92.7%) |
Mar 2007 | - | 10.24%(-114.1%) |
Dec 2006 | -58.24%(+186.9%) | -72.76%(+9228.2%) |
Sep 2006 | - | -0.78%(-106.4%) |
Jun 2006 | - | 12.12%(+474.4%) |
Mar 2006 | - | 2.11%(-93.2%) |
Dec 2005 | -20.30%(+26.8%) | 31.06%(-890.3%) |
Sep 2005 | - | -3.93%(-181.7%) |
Jun 2005 | - | 4.81%(-110.8%) |
Mar 2005 | - | -44.56%(-22.0%) |
Dec 2004 | -16.01%(+87.5%) | -57.15%(-29.7%) |
Sep 2004 | - | -81.34%(+568.4%) |
Jun 2004 | - | -12.17%(+83.8%) |
Mar 2004 | - | -6.62%(-1479.2%) |
Dec 2003 | -8.54%(-58.0%) | 0.48%(-101.8%) |
Sep 2003 | - | -26.86%(-397.1%) |
Jun 2003 | - | 9.04%(-134.5%) |
Mar 2003 | - | -26.17%(-36.6%) |
Dec 2002 | -20.32%(-49.9%) | -41.31%(+44.1%) |
Sep 2002 | - | -28.66%(-201.2%) |
Jun 2002 | - | 28.32%(-127.6%) |
Mar 2002 | - | -102.48%(+0.4%) |
Dec 2001 | -40.55%(-73.1%) | -102.09%(+490.1%) |
Sep 2001 | - | -17.30%(-81.0%) |
Jun 2001 | - | -91.15%(+57.7%) |
Mar 2001 | - | -57.79%(-96.0%) |
Dec 2000 | -150.69%(-8.3%) | -1435.75%(+6252.9%) |
Sep 2000 | - | -22.60%(-54.8%) |
Jun 2000 | - | -50.00%(-75.0%) |
Mar 2000 | - | -200.00%(-87.2%) |
Dec 1999 | -164.25%(+13.9%) | -1566.64%(+4600.4%) |
Sep 1999 | - | -33.33%(-83.3%) |
Jun 1999 | - | -200.00%(+100.0%) |
Mar 1999 | - | -100.00%(-100.5%) |
Dec 1998 | -144.19%(+476.8%) | 21.42 K%(<-9900.0%) |
Sep 1998 | - | -200.00%(+300.0%) |
Jun 1998 | - | -50.00%(-83.3%) |
Mar 1998 | - | -300.00%(-11.1%) |
Dec 1997 | -25.00%(-75.9%) | -337.32%(+57.4%) |
Sep 1997 | - | -214.29%(-54.9%) |
Jun 1997 | - | -475.00%(+39.7%) |
Mar 1997 | - | -340.00% |
Dec 1996 | -103.70% | - |
FAQ
- What is COSCIENS Biopharma annual operating profit margin?
- What is the all time high annual operating margin for COSCIENS Biopharma?
- What is COSCIENS Biopharma annual operating margin year-on-year change?
- What is COSCIENS Biopharma quarterly operating profit margin?
- What is the all time high quarterly operating margin for COSCIENS Biopharma?
- What is COSCIENS Biopharma quarterly operating margin year-on-year change?
What is COSCIENS Biopharma annual operating profit margin?
The current annual operating margin of CSCI is -400.36%
What is the all time high annual operating margin for COSCIENS Biopharma?
COSCIENS Biopharma all-time high annual operating profit margin is 36.61%
What is COSCIENS Biopharma annual operating margin year-on-year change?
Over the past year, CSCI annual operating profit margin has changed by -129.92% (-48.04%)
What is COSCIENS Biopharma quarterly operating profit margin?
The current quarterly operating margin of CSCI is -258.36%
What is the all time high quarterly operating margin for COSCIENS Biopharma?
COSCIENS Biopharma all-time high quarterly operating profit margin is 21.42 K%
What is COSCIENS Biopharma quarterly operating margin year-on-year change?
Over the past year, CSCI quarterly operating profit margin has changed by -99.11% (-62.24%)